On March 31, 2022 Gnubiotics Sciences SA, a biotech company pioneering immunomodulatory glycopeptides reported a poster presentation on the use of Glycopeptides to promote anti-cancer immune response against solid tumors at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2022, scheduled for April 8-13, 2022 in New Orleans, Louisiana (USA) (Press release, Gnubiotics Sciences, MAR 31, 2022, View Source [SID1234611322]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"Our poster presentation at the AACR (Free AACR Whitepaper) will showcase the immunomodulatory and therapeutic potential of our proprietary glycopeptide assets to boost directed anti-tumor immune responses in anti-PD-1 resistant solid tumors. Our innovative Glycopeptides with Tumor and Antigen Associated Delivery (GLAAD) technology has been shown to have the power, through molecular mimicry, to reduce tumor size, either in combination with existing anti-PD-1 treatment or as a monotherapy. The pre-clinical study carried out in collaboration with the University of Zurich indicates that GLAAD treatment may be a safe and effective strategy to potentiate immune checkpoint inhibitor (ICI) therapies in a resistant setting. We expect our GLAAD approach to have a broader utility in immuno-oncology treatments, for example in enabling the efficacy of CAR-T therapies against solid tumors." stated Yemi Adesokan, Ph.D., Gnubiotics` Chief Executive Officer.
The authors on the poster are: Marianne R. Spalinger, Romain Wyss, Sara Vidal, Yong Miao, Michael Scharl, Yemi Adesokan.
The Poster, abstract number 5600, will be made available for browsing on April 8, the first day of the AACR (Free AACR Whitepaper) Annual Meeting 2022 and will remain available for viewing through July 13. Viewers will have the possibility to e-mail questions